| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 539 | 2019 |
| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 410 | 2020 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 384 | 2020 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 274 | 2021 |
| A proteogenomic portrait of lung squamous cell carcinoma S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ... Cell 184 (16), 4348-4371. e40, 2021 | 267 | 2021 |
| The prognostic effects of somatic mutations in ER-positive breast cancer OL Griffith, NC Spies, M Anurag, M Griffith, J Luo, D Tu, B Yeo, J Kunisaki, ... Nature communications 9 (1), 3476, 2018 | 140 | 2018 |
| Endocrine therapy resistance: new insights JT Lei, M Anurag, S Haricharan, X Gou, MJ Ellis The Breast 48, S26-S30, 2019 | 120 | 2019 |
| Functional annotation of ESR1 gene fusions in estrogen receptor-positive breast cancer JT Lei, J Shao, J Zhang, M Iglesia, DW Chan, J Cao, M Anurag, P Singh, ... Cell reports 24 (6), 1434-1444. e7, 2018 | 117 | 2018 |
| Microscaled proteogenomic methods for precision oncology S Satpathy, EJ Jaehnig, K Krug, BJ Kim, AB Saltzman, DW Chan, ... Nature communications 11 (1), 532, 2020 | 116 | 2020 |
| Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness Y Li, TSM Lih, SM Dhanasekaran, R Mannan, L Chen, M Cieslik, Y Wu, ... Cancer Cell 41 (1), 139-163. e17, 2023 | 112 | 2023 |
| Comprehensive profiling of DNA repair defects in breast cancer identifies a novel class of endocrine therapy resistance drivers M Anurag, N Punturi, J Hoog, MN Bainbridge, MJ Ellis, S Haricharan Clinical Cancer Research 24 (19), 4887-4899, 2018 | 87 | 2018 |
| Neurofibromin is an estrogen receptor-α transcriptional co-repressor in breast cancer ZY Zheng, M Anurag, JT Lei, J Cao, P Singh, J Peng, H Kennedy, ... Cancer cell 37 (3), 387-402. e7, 2020 | 83 | 2020 |
| Loss of MutL Disrupts Chk2-dependent Cell Cycle Control Through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer Cancer Discovery, 2017 | 83 | 2017 |
| Proteogenomic data and resources for pan-cancer analysis Y Li, Y Dou, FDV Leprevost, Y Geffen, AP Calinawan, F Aguet, Y Akiyama, ... Cancer cell 41 (8), 1397-1406, 2023 | 79 | 2023 |
| Immune checkpoint profiles in luminal B breast cancer (Alliance) M Anurag, M Zhu, C Huang, S Vasaikar, J Wang, J Hoog, S Burugu, ... JNCI: Journal of the National Cancer Institute 112 (7), 737-746, 2020 | 72 | 2020 |
| Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation Y Geffen, S Anand, Y Akiyama, TM Yaron, Y Song, JL Johnson, ... Cell 186 (18), 3945-3967. e26, 2023 | 70 | 2023 |
| Proteogenomic markers of chemotherapy resistance and response in triple-negative breast cancer M Anurag, EJ Jaehnig, K Krug, JT Lei, EJ Bergstrom, BJ Kim, TD Vashist, ... Cancer discovery 12 (11), 2586-2605, 2022 | 65 | 2022 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 180 (1), 207, 2020 | 59 | 2020 |
| Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort AS Cheng, SCY Leung, D Gao, S Burugu, M Anurag, MJ Ellis, TO Nielsen Breast cancer research and treatment 179, 3-10, 2020 | 52 | 2020 |
| Pan-cancer proteogenomics connects oncogenic drivers to functional states Y Li, E Porta-Pardo, C Tokheim, MH Bailey, TM Yaron, V Stathias, ... Cell 186 (18), 3921-3944. e25, 2023 | 49 | 2023 |
Matthew J. EllisGuardant Health Palo Alto CAยืนยันอีเมลแล้วที่ guardanthealth.com
